Xadago
These highlights do not include all the information needed to use XADAGO safely and effectively. See full prescribing information for XADAGO . XADAGO (safinamide) tablets, for oral use. Initial U.S. Approval: 2017
c4d65f28-983f-42b4-bb23-023ae0fe81b2
HUMAN PRESCRIPTION DRUG LABEL
Dec 20, 2023
MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
DUNS: 087875626
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
safinamide mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
safinamide mesylate
Product Details
FDA regulatory identification and product classification information